Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSC127 in Diabetic Ulcers
NCT00796744Phase 2Completed
- Sponsor
- US Biotest, Inc.
- Start
- Oct 2008
- Primary completion
- Dec 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aclerastide in diabetic foot ulcer (DFU), sponsored by US Biotest, Inc.. Started Oct 2008; status: completed.
02
Drugs
aclerastide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00796744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796744.